In July 2025, a class 2 resubmission of tab-cel’s BLA was initiated by Atara Biotherapeutics, developer and sponsor of ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
Background: Hypertension-related chronic kidney disease (HT-CKD) represents a global health threat exacerbated by modifiable metabolic risks. Elevated body mass index (BMI) and low physical activity ...